Mitumomab Uses, Dosage, Side Effects and more
Mitumomab, an anti-BEC-2 monoclonal antibody derived from mice, was previously studied to treat small cell lung carcinoma in combination with BCG vaccination.
| Trade Name | Mitumomab |
| Generic | Mitumomab |
| Mitumomab Other Names | BEC2, Mitumomab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in lung cancer and melanoma.
